Premium
Response of Postpoliomyelitis Patients to Bisphosphonate Treatment
Author(s) -
Alvarez Arodi,
Kremer Richard,
Weiss Deborah R.,
Benedetti Andrea,
Haziza Muriel,
Trojan Daria A.
Publication year - 2010
Publication title -
pmandr
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.617
H-Index - 66
eISSN - 1934-1563
pISSN - 1934-1482
DOI - 10.1016/j.pmrj.2010.08.009
Subject(s) - medicine , bone mineral , odds ratio , poisson regression , confidence interval , osteoporosis , logistic regression , surgery , bisphosphonate , population , environmental health
Objective To evaluate (1) the rate of change of bone mineral density (BMD) at the hip in postpolio patients treated with bisphosphonates compared with the rate of change in BMD in (a) postpolio patients not treated with bisphosphonates and (b) non‐postpolio patients treated with bisphosphonates; and (2) to compare the fracture rate in postpolio patients before and after treatment. Design Retrospective chart review. Setting University‐affiliated hospital postpolio clinic and bone metabolism clinic. Participants Patients with at least 2 BMD assessments. We included 144 postpolio patients and 112 non‐postpolio patients. For the fracture analysis, 32 postpolio patients with a history of fractures and treatment with bisphosphonates were included. Methods The effect of treatment on BMD in postpolio patients was analyzed with use of a multiple linear regression model and a mixed effects model, with the rate of change in hip BMD and the change in BMD from baseline, respectively, as the dependent variables. The effect of treatment on occurrence of fractures in postpolio patients was analyzed with use of conditional logistic regression and Poisson regression. Main Outcome Measures BMD measurements at the femoral neck (g/cm 2 ) and occurrence of fractures before and after initiation of treatment. Results In an adjusted model, postpolio patients treated with bisphosphonates (54/144) had a greater rate of change in BMD (0.031 g/cm 2 /year; 95% confidence interval 0.010‐0.052) compared with nontreated postpolio patients. The effect of treatment in postpolio patients was similar to that in non‐postpolio patients. Evidence indicated that treated postpolio patients have a lower risk of fracture after treatment (odds ratio 0.3, P = .046; rate ratio 0.4, P = .183). Conclusions In this retrospective study, it was found that treatment with oral bisphosphonates significantly increases BMD at the hip in postpolio patients. The effect of bisphosphonate treatment appears to be similar in postpolio patients compared with a control group without polio. Treatment with bisphosphonates may have a protective effect on fracture risk in this population.